Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pruijt, Hans F.M."'
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial
Autor:
Linn, Sabine C., Soesan, Marcel, Oosterkamp, Rianne M., Jeurissen, Frank, Weijl, Nir, Imholz, Alex L.T., Portielje, Johanneke E.A., Beelen, Karin J., Bos, Monique E.M.M., van Bochove, Aart, de Klerk, Gerty, Vrijaldenhoven, Suzan, van der Velden, Annette, de Graaf, Hiltje, Smeets, Marielle, Terwogt, Jetske Meerum, Schrama, Jolanda, Kuijer, Philomeen, Wilmink, Hanneke, Hoekstra, Ronald, Kroep, Judith, Pruijt, Hans F.M., van Gerven, Leander, Vos, Allert H., Erdkamp, Frans, van Leeuwen-Breuk, Willemien G., de Graeff, Alexander, Opdam, Mark, van Rossum, Annelot G.J., Hoogstraat, Marlous, Bounova, Gergana, Horlings, Hugo M., van Werkhoven, Erik, Mandjes, Ingrid A.M., van Leeuwen – Stok, A. Elise, Canisius, Sander, van Tinteren, Harm, Bakker, Sandra, Wesseling, Jelle, Kester, Lennart, van Rheenen, Jacco, Rutgers, Emiel J., de Menezes, Renee X., Wessels, Lodewyk F.A., Kok, Marleen, Oosterkamp, Hendrika M.
Publikováno v:
In iScience 16 August 2024 27(8)
Autor:
van Putten, Margreet, Lemmens, Valery E.P.P., van Laarhoven, Hanneke W.M., Pruijt, Hans F.M., Nieuwenhuijzen, Grard A.P., Verhoeven, Rob H.A.
Publikováno v:
In European Journal of Surgical Oncology October 2019 45(10):1926-1933
Autor:
Razenberg, Lieke G.E.M., van Erning, Felice N., Pruijt, Hans F.M., ten Tije, Albert J., van Riel, Johanna M.G.H., Creemers, Geert-Jan, Lemmens, Valery E.P.P.
Publikováno v:
In Journal of Geriatric Oncology January 2017 8(1):37-43
Autor:
Schraa, S. J., Van Rooijen, K. L., Van Der Kruijssen, D. E.W., Rubio Alarcón, C., Phallen, J., Sausen, M., Simmons, J., Coupé, V. M.H., Van Grevenstein, W. M.U., Elias, S., Verkooijen, H. M., Laclé, M. M., Bosch, L. J.W., Van Den Broek, D., Meijer, G. A., Velculescu, V. E., Fijneman, R. J.A., Vink, G. R., Koopman, M., Dunker, Mich S., Lutke Holzik, Martijn F., Hoekstra, Ronald, Sommeijer, Dirkje W., Van Der Bilt, Jarmila D.W., Consten, Esther C.J., Cirkel, Geert A., Burghgraef, Thijs A., Van Der Schans, Emma M., Nieboer, Peter, Rietbroek, Ron C., Dekker, Jan Willem T., Verschoor, Arjan J., Talsma, Koen A.K., Brosens, Rebecca P.M., Helgason, Helgi H., Marinelli, Andreas W.K.S., De Hingh, Ignace H.J.T., Oldenhuis, Corina N., Jansen, Jan, Van Halteren, Henk K., Stockmann, Hein B.A.C., Beeker, Aart, Bosscha, Koop, Pruijt, Hans F.M., Spierings, Leontine E.A.M.M., Valkenburg-Van Iersel, Liselot B.J., Vles, Wouter J., De Jongh, Felix E., Van Cruijsen, Hester, Heikens, Joost T., Zimmerman, David D.E., Van Alphen, Robert J., Schiphorst, Anandi H.W., Van Leeuwen-Snoeks, Lobke L., Vogelaar, Jeroen F.J., Peters, Natascha A.J.B.
Publikováno v:
BMC Cancer, 20(1):790. BioMed Central
BMC Cancer, 20(1):790. BMC
BMC Cancer
Schraa, S J, Van Rooijen, K L, Van Der Kruijssen, D E W, Rubio Alarcón, C, Phallen, J, Sausen, M, Simmons, J, Coupé, V M H, Van Grevenstein, W M U, Elias, S, Verkooijen, H M, Laclé, M M, Bosch, L J W, Van Den Broek, D, Meijer, G A, Velculescu, V E, Fijneman, R J A, Vink, G R, Koopman, M, Dunker, M S, Lutke Holzik, M F, Hoekstra, R, Sommeijer, D W, Van Der Bilt, J D W, Consten, E C J, Cirkel, G A, Burghgraef, T A, Van Der Schans, E M, Nieboer, P, Rietbroek, R C, Dekker, J W T, Verschoor, A J, Talsma, K A K, Brosens, R P M, Helgason, H H, Marinelli, A W K S, De Hingh, I H J T, Oldenhuis, C N, Jansen, J, Van Halteren, H K, Stockmann, H B A C, Beeker, A, Bosscha, K, Pruijt, H F M, Spierings, L E A M M, Valkenburg-Van Iersel, L B J, Vles, W J, De Jongh, F E, Van Cruijsen, H, Heikens, J T, Zimmerman, D D E, Van Alphen, R J, Schiphorst, A H W, Van Leeuwen-Snoeks, L L, Vogelaar, J F J & Peters, N A J B 2020, ' Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE) : Study protocol for a trial within a cohort study ', BMC Cancer, vol. 20, no. 1, 790 . https://doi.org/10.1186/s12885-020-07252-y
BMC Cancer, 20(1):790. BioMed Central Ltd
BMC cancer, 20(1):790. BioMed Central
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer, 20(1):790. BMC
BMC Cancer
Schraa, S J, Van Rooijen, K L, Van Der Kruijssen, D E W, Rubio Alarcón, C, Phallen, J, Sausen, M, Simmons, J, Coupé, V M H, Van Grevenstein, W M U, Elias, S, Verkooijen, H M, Laclé, M M, Bosch, L J W, Van Den Broek, D, Meijer, G A, Velculescu, V E, Fijneman, R J A, Vink, G R, Koopman, M, Dunker, M S, Lutke Holzik, M F, Hoekstra, R, Sommeijer, D W, Van Der Bilt, J D W, Consten, E C J, Cirkel, G A, Burghgraef, T A, Van Der Schans, E M, Nieboer, P, Rietbroek, R C, Dekker, J W T, Verschoor, A J, Talsma, K A K, Brosens, R P M, Helgason, H H, Marinelli, A W K S, De Hingh, I H J T, Oldenhuis, C N, Jansen, J, Van Halteren, H K, Stockmann, H B A C, Beeker, A, Bosscha, K, Pruijt, H F M, Spierings, L E A M M, Valkenburg-Van Iersel, L B J, Vles, W J, De Jongh, F E, Van Cruijsen, H, Heikens, J T, Zimmerman, D D E, Van Alphen, R J, Schiphorst, A H W, Van Leeuwen-Snoeks, L L, Vogelaar, J F J & Peters, N A J B 2020, ' Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE) : Study protocol for a trial within a cohort study ', BMC Cancer, vol. 20, no. 1, 790 . https://doi.org/10.1186/s12885-020-07252-y
BMC Cancer, 20(1):790. BioMed Central Ltd
BMC cancer, 20(1):790. BioMed Central
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Background Accurate detection of patients with minimal residual disease (MRD) after surgery for stage II colon cancer (CC) remains an urgent unmet clinical need to improve selection of patients who might benefit form adjuvant chemotherapy (ACT). Pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cf63edddef375423268bb260e222f55
https://research.vumc.nl/en/publications/8b8e8f3b-daeb-4c5b-a990-04e398b497c4
https://research.vumc.nl/en/publications/8b8e8f3b-daeb-4c5b-a990-04e398b497c4
Autor:
van Erning, Felice N., Janssen-Heijnen, Maryska L.G., Creemers, Geert-Jan, Pruijt, Hans F.M., Maas, Huub A.A.M., Lemmens, Valery E.P.P.
Publikováno v:
In Journal of Geriatric Oncology May 2015 6(3):219-224